Rare disease-based scientific annotation knowledge graph
- PMID: 36034595
- PMCID: PMC9403737
- DOI: 10.3389/frai.2022.932665
Rare disease-based scientific annotation knowledge graph
Abstract
Rare diseases (RDs) are naturally associated with a low prevalence rate, which raises a big challenge due to there being less data available for supporting preclinical and clinical studies. There has been a vast improvement in our understanding of RD, largely owing to advanced big data analytic approaches in genetics/genomics. Consequently, a large volume of RD-related publications has been accumulated in recent years, which offers opportunities to utilize these publications for accessing the full spectrum of the scientific research and supporting further investigation in RD. In this study, we systematically analyzed, semantically annotated, and scientifically categorized RD-related PubMed articles, and integrated those semantic annotations in a knowledge graph (KG), which is hosted in Neo4j based on a predefined data model. With the successful demonstration of scientific contribution in RD via the case studies performed by exploring this KG, we propose to extend the current effort by expanding more RD-related publications and more other types of resources as a next step.
Keywords: PubMed; knowledge graph; natural language processing; rare disease (RD); scientific annotations.
Copyright © 2022 Zhu, Qu, Liu, Vatas, Clough, Nguyễn, Sid, Mathé and Xu.
Conflict of interest statement
GV worked at HHS and is employed by GMG ArcData, LLC. AC worked at HHS and is employed by Data Decode, LLC. Ð-TN worked at NCATS and is employed by Pfizer. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





References
-
- Chen C. L., Cheng M. H., Kuo C. F., Cheng Y. L., Li M. H., Chang C. P., et al. . (2018). Dextromethorphan attenuates NADPH oxidase-regulated glycogen synthase kinase 3β and NF-κB activation and reduces nitric oxide production in group A streptococcal infection. Antimicrob. Agents Chemotherapy 62, e02045–e02017. 10.1128/AAC.02045-17 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous